Table 2.
Patient distribution and median value of aerated residual lung volume for each subgroup.
| Unvaccinated | Vaccinated with 2 Doses |
Vaccinated with 3 Doses |
p Value | ||
|---|---|---|---|---|---|
| Patients with Alpha Variant | Number of patients | 20 | 0 | 0 | 0.001 |
| Patients with Delta variant | 20 | 16 | 2 | ||
| Patients with Omicron | 20 | 8 | 5 | ||
| Patients with Alpha Variant | Median value of (range) of Aerated residual lung volume [%] | 39.95 (19.40–67.50) |
- | - | 0.05 |
| Patients with Delta variant | 46.7 (13.60–75.60) |
67.10 (17.10–89.80) |
52.00 (19.40–84.50) |
||
| Patients with Omicron | 48.35 (8.20–83.30) |
38.30 (18.90–73.30) |
61.9 (31.60–73.60) |